Fortrea Holdings (FTRE) Earnings Analysis
Fortrea Holdings (FTRE) next reports earnings on 2026-07-29, consensus EPS 0.18 USD. Last quarter (2026-02-26) it missed with EPS 0.09 USD vs 0.16 USD est (-43.8%). It has beaten estimates in 1/5 recent quarters (20%). Trailing P/E -3.75.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does FTRE next report earnings?
| Next earnings date | 2026-07-29 |
|---|---|
| Consensus EPS estimate | 0.18 USD |
| Revenue estimate | 0.65B |
FTRE earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-02-26 | 0.09 USD | 0.16 USD | -43.8% | Miss |
| 2025-05-12 | 0.02 USD | -0.07 USD | +128.6% | Beat |
| 2025-03-03 | 0.18 USD | 0.36 USD | -50% | Miss |
| 2024-11-08 | 0.23 USD | 0.27 USD | -14.8% | Miss |
| 2024-08-12 | -0.03 USD | 0.07 USD | -142.9% | Miss |
Beat rate: 1/5 (20%) over reported quarters with consensus data.
FTRE valuation and analyst view
| Trailing P/E | -3.75 |
|---|---|
| Trailing EPS | -4.90022 USD |
| Price / book | 3.21 |
| Dividend yield | 0.00% |
| Market cap | 1.71B |
| Analyst consensus | Hold (5 buy / 6 hold / 1 sell) |
| Avg price target | 17.17 USD |
Related research pages
Frequently asked questions
When is Fortrea Holdings (FTRE)'s next earnings date?
Fortrea Holdings is next scheduled to report on 2026-07-29, with a consensus EPS estimate of 0.18 USD and revenue estimate of 0.65B.
Did FTRE beat earnings last quarter?
In its 2026-02-26 report, FTRE posted EPS of 0.09 USD versus a 0.16 USD estimate — a miss of 43.8%.
What is FTRE's earnings track record?
Over the last 5 reported quarters with consensus data, FTRE beat estimates 1 times (20%).
What is FTRE's current P/E ratio and EPS?
FTRE trades at a trailing P/E of -3.75 on trailing EPS of -4.900219298245614 USD.
What do analysts rate FTRE?
Analyst consensus is "Hold" across 12 ratings (0 strong buy, 5 buy, 6 hold, 1 sell, 0 strong sell). Average 12-month price target: 17.17 USD.